NCT02545842 - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) | Biotech Hunter

Enrollment

947

Participants

Timeline

Start Date

September 7, 2015

Primary Completion Date

April 20, 2018

Study Completion Date

April 20, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

INSULIN GLARGINE

"Pharmaceutical form: solution~Route of administration: subcutaneous"

Trial Locations (44)

130033

Investigational Site Number 156013, Changchun

Investigational Site Number 156014, Changchun

212001

Investigational Site Number 156032, Zhenjiang

300032

Investigational Site Number 156010, Tianjin

310013

Investigational Site Number 156039, Hangzhou

330006

Investigational Site Number 156020, Nanchang

412000

Investigational Site Number 156025, Zhuzhou

415000

Investigational Site Number 156022, Changde

430000

Investigational Site Number 156055, Wuhan

510515

Investigational Site Number 156026, Guangzhou

570102

Investigational Site Number 156029, Haikou

Unknown

Investigational Site Number 156053, Anshan

Investigational Site Number 156001, Beijing

Investigational Site Number 156002, Beijing

Investigational Site Number 156006, Beijing

Investigational Site Number 156017, Changsha

Investigational Site Number 156034, Changzhou

Investigational Site Number 156023, Chenzhou

Investigational Site Number 156028, Haikou

Investigational Site Number 156040, Haikou

Investigational Site Number 156038, Hangzhou

Investigational Site Number 156042, Hangzhou

Investigational Site Number 156044, Hangzhou

Investigational Site Number 156048, Hefei

Investigational Site Number 156050, Hefei

Investigational Site Number 156011, Kunming

Investigational Site Number 156052, Kunming

Investigational Site Number 156016, Lanzhou

Investigational Site Number 156041, Lishui

Investigational Site Number 156018, Nanchang

Investigational Site Number 156019, Nanchang

Investigational Site Number 156031, Nanjing

Investigational Site Number 156043, Nanjing

Investigational Site Number 156049, Nanjing

Investigational Site Number 156035, Shanghai

Investigational Site Number 156036, Shanghai

Investigational Site Number 156047, Shanghai

Investigational Site Number 156027, Shantou

Investigational Site Number 156015, Shenyang

Investigational Site Number 156054, Shijiazhuang

Investigational Site Number 156037, Xuzhou

Investigational Site Number 156033, Yangzhou

Investigational Site Number 156030, Yueyang

063000

Investigational Site Number 156007, Tangshan